The sL1CAM in sera of patients with endometrial and ovarian cancers.
Michal WojciechowskiEwa GłowackaMiłosz WilczyńskiAnna Pękala-WojciechowskaAndrzej MalinowskiPublished in: Archives of gynecology and obstetrics (2016)
Despite the increasing data about the possible role of L1CAM as a strong prognostic factor of poor outcome in many cancers, we did not find evidence supporting the use of sL1CAM as a marker of endometrial or ovarian cancers.